Rocuronium Bromide Injection Shortage: Current Availability and Manufacturer Updates
Rocuronium Bromide Injection, a medication used in anesthesia, is currently in shortage with some manufacturers reporting limited availability while others remain in supply.
What’s in Shortage
Rocuronium Bromide Injection (brand names: ROCURONIUM BROMIDE, ROCURONIUM) is currently listed as being in shortage. This medication belongs to the therapeutic category of Anesthesia. The shortage affects various presentations of the injection, including 10 mg/1 mL, 50 mg/5 mL, and 100 mg/10 mL dosages.
Which Manufacturers Are Affected
Several manufacturers are involved in the production of Rocuronium Bromide Injection, with varying levels of availability:
- Mylan Institutional, a Viatris Company:
- 10 mg/1 mL (NDC 67457-228-05): Available
- 10 mg/1 mL (NDC 67457-228-10): Unavailable (Re-supply expected March 2026)
- Contact: 800-796-9526
- Fresenius Kabi USA, LLC:
- 10 mg/1 mL (NDC 65219-444-10): Available (Check wholesalers for inventory)
- 10 mg/1 mL (NDC 63323-426-05): Unavailable (Next release expected March 2026; check wholesalers for inventory)
- Contact: 888-386-1300
- Sagent Pharmaceuticals:
- 10 mg/1 mL (NDC 25021-687-05): Available
- Contact: 866-625-1618
- Eugia US LLC:
- 100 mg/10 mL (NDC 55150-226-10): Available (Check wholesalers for inventory)
- 50 mg/5 mL (NDC 55150-225-05): Available (Check wholesalers for inventory)
- Contact: 888-238-7880
- Baxter Healthcare:
- 50 mg/5 mL (NDC 43066-007-10): Available
- 100 mg/10 mL (NDC 43066-013-10): Available
- Contact: 888-229-0001
- Sandoz Inc.:
- 10 mg/1 mL (NDC 0781-3220-95): Available
- 10 mg/1 mL (NDC 0781-3220-92): Available
- Contact: 800-525-8747
Why There’s a Shortage
No specific reason for the shortage was provided in the official documentation. Some manufacturers have indicated that re-supply or next releases for specific presentations are expected in March 2026.
What Patients Should Do
Rocuronium Bromide is typically administered by healthcare professionals in a clinical or hospital setting. If you are a patient with concerns about this medication’s availability for an upcoming procedure, please:
- Consult with your healthcare provider or anesthesiologist regarding your treatment plan.
- Ask your pharmacist or hospital supply coordinator about current inventory levels.
- Healthcare facilities may contact the manufacturers directly using the phone numbers provided above for the most current shipping information.
Patients should always consult their healthcare provider regarding any changes to their medical care.
Source
Information provided by the FDA Drug Shortage Database.
Initial Posting Date: 02/15/2023
Last Updated: 02/05/2026
Source: FDA Official Notice
Related Articles
Streptozocin (Zanosar) Oncology Medication Facing Ongoing Supply Shortage
FDA · February 11, 2026
Cromolyn Sodium Concentrate (Gastrocrom) Shortage: Current FDA Status and Availability
FDA · February 11, 2026
Quinapril/Hydrochlorothiazide Tablet Shortage: Current FDA Status and Availability Updates
FDA · February 11, 2026